Literature DB >> 18774945

A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis.

Mhairi C Towler1, Sarah Fogarty, Simon A Hawley, David A Pan, David M A Martin, Nicolas A Morrice, Afshan McCarthy, María N Galardo, Silvina B Meroni, Selva B Cigorraga, Alan Ashworth, Kei Sakamoto, D Grahame Hardie.   

Abstract

LKB1 was discovered as a tumour suppressor mutated in Peutz-Jeghers syndrome, and is a gene involved in cell polarity as well as an upstream protein kinase for members of the AMP-activated protein kinase family. We report that mammals express two splice variants caused by alternate usage of 3'-exons. LKB1(L) is the previously described form, while LKB1(S) is a novel form in which the last 63 residues are replaced by a unique 39-residue sequence lacking known phosphorylation (Ser(431)) and farnesylation (Cys(433)) sites. Both isoforms are widely expressed in rodent and human tissues, although LKB1(S) is particularly abundant in haploid spermatids in the testis. Male mice in which expression of Lkb1(S) is knocked out are sterile, with the number of mature spermatozoa in the epididymis being dramatically reduced, and those spermatozoa that are produced have heads with an abnormal morphology and are non-motile. These results identify a previously undetected variant of LKB1, and suggest that it has a crucial role in spermiogenesis and male fertility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774945     DOI: 10.1042/BJ20081447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

2.  Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation.

Authors:  Wenguang Cao; Muhammad Sohail; Guodong Liu; Geremy A Koumbadinga; Vincent G Lobo; Jiuyong Xie
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

3.  A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.

Authors:  Lu Chen; Brienne E Engel; Eric A Welsh; Sean J Yoder; Stephen G Brantley; Dung-Tsa Chen; Amer A Beg; Chunxia Cao; Frederic J Kaye; Eric B Haura; Matthew B Schabath; W Douglas Cress
Journal:  J Thorac Oncol       Date:  2016-02-23       Impact factor: 15.609

Review 4.  The LKB1 complex-AMPK pathway: the tree that hides the forest.

Authors:  Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 5.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

6.  Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.

Authors:  Huaiping Zhu; Cate M Moriasi; Miao Zhang; Yu Zhao; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation.

Authors:  Simon A Hawley; Fiona A Ross; Cyrille Chevtzoff; Kevin A Green; Ashleigh Evans; Sarah Fogarty; Mhairi C Towler; Laura J Brown; Oluseye A Ogunbayo; A Mark Evans; D Grahame Hardie
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

8.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

9.  Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP.

Authors:  Sarah Fogarty; Simon A Hawley; Kevin A Green; Nazan Saner; Kirsty J Mustard; D Grahame Hardie
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

10.  C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.

Authors:  Sarah Fogarty; D Grahame Hardie
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.